SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Moria H Belanger, Lena Dolman, Suzanna L Arcand, Zhen Shen, George Chong, Anne-Marie Mes-Masson, Diane Provencher, Patricia N Tonin, A targeted analysis identifies a high frequency of BRCA1 and BRCA2 mutation carriers in women with ovarian cancer from a founder population, Journal of Ovarian Research, 2015, 8, 1

    CrossRef

  2. 2
    Giulia Girolimetti, Anna Myriam Perrone, Donatella Santini, Elena Barbieri, Flora Guerra, Simona Ferrari, Claudio Zamagni, Pierandrea De Iaco, Giuseppe Gasparre, Daniela Turchetti, BRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk Management, BioMed Research International, 2014, 2014, 1

    CrossRef

  3. 3
    James R. Conner, Emily Meserve, Ellen Pizer, Judy Garber, Michael Roh, Nicole Urban, Charles Drescher, Bradley J. Quade, Michael Muto, Brooke E. Howitt, Mark D. Pearlman, Ross S. Berkowitz, Neil Horowitz, Christopher P. Crum, Colleen Feltmate, Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations, Gynecologic Oncology, 2014, 132, 2, 280

    CrossRef

  4. 4
    Ramez N Eskander, Krishnansu S Tewari, PARP inhibition and synthetic lethality in ovarian cancer, Expert Review of Clinical Pharmacology, 2014, 7, 5, 613

    CrossRef

  5. 5
    J. L. Meisel, D. M. Hyman, K. Garg, Q. Zhou, F. Dao, M. Bisogna, J. Gao, N. D. Schultz, R. N. Grisham, M. Phillips, A. Iasonos, N. D. Kauff, D. A. Levine, R. A. Soslow, D. R. Spriggs, The performance of BRCA1 immunohistochemistry for detecting germline, somatic, and epigenetic BRCA1 loss in high-grade serous ovarian cancer, Annals of Oncology, 2014, 25, 12, 2372

    CrossRef

  6. 6
    Panagiotis A Konstantinopoulos, Ursula A Matulonis, BRCA status in epithelial ovarian cancer: implications for management and future clinical trial design, Clinical Investigation, 2013, 3, 8, 777

    CrossRef

  7. 7
    Naoto Furukawa, Sumire Ohno, Takahiko Kasai, Sachiko Morioka, Fuminori Ito, Yasuhito Tanase, Shoji Haruta, Seiji Kanayama, Ryuji Kawaguchi, Shozo Yoshida, Hiroshi Kobayashi, Evaluation of the <i>BRCA</i>1/2 mutation as a prognostic marker in primary peritoneal serous cancer, Open Journal of Obstetrics and Gynecology, 2013, 03, 09, 653

    CrossRef

  8. 8
    Dana Meaney-Delman, Cecelia A. Bellcross, Hereditary Breast/Ovarian Cancer Syndrome, Obstetrics and Gynecology Clinics of North America, 2013, 40, 3, 475

    CrossRef

  9. 9
    J. R. McLaughlin, B. Rosen, J. Moody, T. Pal, I. Fan, P. A. Shaw, H. A. Risch, T. A. Sellers, P. Sun, S. A. Narod, Long-Term Ovarian Cancer Survival Associated With Mutation in BRCA1 or BRCA2, JNCI Journal of the National Cancer Institute, 2013, 105, 2, 141

    CrossRef

  10. 10
    P. M. L. H. Vencken, W. Reitsma, M. Kriege, M. J. E. Mourits, G. H. de Bock, J. A. de Hullu, A. M. van Altena, K. N. Gaarenstroom, H. F. A. Vasen, M. A. Adank, M. K. Schmidt, M. van Beurden, R. P. Zweemer, F. Rijcken, B. F. M. Slangen, C. W. Burger, C. Seynaeve, Outcome of BRCA1- compared with BRCA2-associated ovarian cancer: a nationwide study in the Netherlands, Annals of Oncology, 2013, 24, 8, 2036

    CrossRef

  11. 11
    Susan M. Domchek, Komal Jhaveri, Sujata Patil, Jill E. Stopfer, Clifford Hudis, Jacquelyn Powers, Zsofia Stadler, Laura Goldstein, Noah Kauff, Mustafa Khasraw, Kenneth Offit, Katherine L. Nathanson, Mark Robson, Risk of metachronous breast cancer after BRCA mutation–associated ovarian cancer, Cancer, 2013, 119, 7
  12. 12
    Tally Levy, Roi Weiser, Mona Boaz, Erez Ben Shem, Abraham Golan, Joseph Menczer, The significance of the pattern of serum CA125 level ascent to above the normal range in epithelial ovarian, primary peritoneal and tubal carcinoma patients, Gynecologic Oncology, 2013, 129, 1, 165

    CrossRef

  13. 13
    Guoyan Liu, Da Yang, Yan Sun, Ilya Shmulevich, Fengxia Xue, Anil K Sood, Wei Zhang, Differing clinical impact ofBRCA1andBRCA2mutations in serous ovarian cancer, Pharmacogenomics, 2012, 13, 13, 1523

    CrossRef

  14. 14
    David M. Hyman, Kara C. Long, Edward J. Tanner, Rachel N. Grisham, Angela G. Arnold, Jasmine Bhatia, Mary F. Phillips, David R. Spriggs, Robert A. Soslow, Noah D. Kauff, Douglas A. Levine, Outcomes of primary surgical cytoreduction in patients with BRCA-associated high-grade serous ovarian carcinoma, Gynecologic Oncology, 2012, 126, 2, 224

    CrossRef